Fact CheckerSign in

NCT07151664Not yet recruiting

Retrospective Analysis of Quality of Life Changes in Patients Undergoing Parathyroidectomy for End-Stage Renal Disease

Quality of Life Change in Patients Undergoing Parathyroidectomy With Secondary Hyperparathyroidism Due toEnd-stage Renal Failure: a Retrospective Cohort Study

Source: ClinicalTrials.gov · Last updated 3 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to characterize changes in quality of life in patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease, based on data extracted from an established database

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
60 (estimated)
First submitted
25 Aug 2025
Start date
5 Sept 2025
Primary completion date
5 Dec 2025
Lead sponsor
West China Hospital
NCT number
NCT07151664

What you commit to

  • Study type: Observational
  • Planned participants: 60
  • From 5 Sept 2025 to the primary completion date, 5 Dec 2025
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who underwent kidney transplantation during the study period. Patients with postoperative whole blood parathyroid hormone levels \>300 pg/mL within the first week after surgery.

Other

  • Patients with missing postoperative quality of life assessment data.

Who the study is looking for

  • Age ≥18 years; Patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.